Abbott announced a definitive agreement to acquire Exact Sciences for up to $23 billion. Under the deal, Exact Sciences shareholders will receive $105 per common share in cash. The transaction is expected to close in second quarter of 2026, subject to receipt of necessary approvals. The transaction was unanimously approved by both companies' boards of directors, the companies said.